- FDA Approves Voquezna for Helicobacter pylori Infection in Adults
Phathom Pharmaceuticals announces FDA approval of Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) for the treatment of H pylori infection in adults News release Phathom Pharmaceuticals May 3, 2022 Accessed August 16, 2022
- With FDA Approval, Vonoprozan Offers Options for Nonerosive GERD
The FDA has approved vonoprazan (Voquenza) 10 mg tablets for relief of heartburn associated with nonerosive gastroesophageal reflux disease (GERD) in adults 1 This represents the third FDA approval for vonoprazan; the drug is also approved to treat erosive esophagitis or erosive GERD and Helicobacter pylori infection, in combination with antibiotics
- Authors - Drug Topics
Drug Topics connects pharmacists across retail, health system, and specialty practice with clinical updates, pharmacy trends, and regulatory news
- Tips for Managing Diabetes Comorbidities - drugtopics. com
Considering comorbidities is just as important as lowering patient HbA1c Common comorbidities in patients with type 2 diabetes include hypertension, lipid disorders, heart disease, and obesity 1,2 As accessible health care professionals, pharmacists are uniquely positioned to counsel and encourage patients with diabetes to manage comorbidities
- Gabriella Salerno, PharmD
Drug Topics connects pharmacists across retail, health system, and specialty practice with clinical updates, pharmacy trends, and regulatory news
- Cannabis Treatment for Sleep Disorders Warrants Further Investigation
A review published in Nature and Science of Sleep 1 found promising results of cannabinoid medicine on sleep disorders—an indication that further research exploring this relationship would be helpful in this field
- The Evolution of the CBD Regulatory Landscape - Drug Topics
At best, the regulation of cannabidiol (CBD) in the United States can be described as patchwork On a federal level, any part or constituent of Cannabis sativa plants, more commonly known as cannabis or marijuana, is a Schedule I controlled substance
- Mitigating Costs of Cancer Treatment: The Role of Pharmacists - Drug Topics
Cancer care is expensive, but pharmacists can help Cancer care is associated with considerable financial toxicities, both in terms of out-of-pocket costs to patients and caregivers as well as burdens placed on the healthcare system at large 1 Drug Topics® interviewed several experts to discuss the role of pharmacists in mitigating costs associated with cancer care
|